-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- This Week in PLOS NTD and PLOS Pathogens: Plant-Virus Ecology; a Genomic Strategy Against P. falciparum; Protective Sand Fly Saliva Proteins; and More in Work In Progress
- Violence Against Women: Implications for our communities, our world and our future in Work In Progress
- University of Geneva hosts Citizen Cyberscience in Work In Progress
- Toms River: A New Classic in Epidemiology Writing in Work In Progress
- Hairy, Sticky Leg Pads are In: How Different Spiders Hunt in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013. 
jessicawapner:
aragornfischer (Charles Fischer)
RhinebeckTweets (RhinebeckTweets)
OblongBooks (Oblong Books & Music)
HenrySantoro (HenrySantoro)
PLOS (PLOS)